Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06001268 · ClinicalTrials.gov registry record · NA

Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)

A NA study of Pancreatic Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT06001268 is a NA study of Pancreatic Cancer that is actively recruiting participants, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 80 participants, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06001268, a NA study of Pancreatic Cancer, is actively recruiting participants, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to assess the feasibility and participant satisfaction with the Support through Remote Observation and Nutrition Guidance program. The program provides enhanced dietician access and nutrition support for participants living with pancreatic cancer who are undergoing surgery.

Conditions Studied

Interventions

  • BEHAVIORAL Fitbit Data Collection
  • BEHAVIORAL Nutrition Counseling
  • BEHAVIORAL Survey

Study Locations (1)

Florida

  • Moffitt Cancer Center - Tampa

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2023-08-14
Est. Completion 2027-08
Phase NA

What the Registry Record Tells You About NCT06001268

The ClinicalTrials.gov registry entry for NCT06001268 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (80% lower). The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pancreatic Cancer appearing as the primary indexed condition, and to 3 interventions - of which Fitbit Data Collection is the first listed.

NCT06001268 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06001268 about?

NCT06001268 is a clinical study titled "Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)". The purpose of the study is to assess the feasibility and participant satisfaction with the Support through Remote Observation and Nutrition Guidance program. The program provides enhanced dietician access and nutrition support for participants living with pancreatic cancer who are undergoing surger...

What is the current status of trial NCT06001268?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-08-14. Estimated completion is 2027-08.

What conditions does trial NCT06001268 study?

This clinical trial studies the following conditions: Pancreatic Cancer.

What interventions are being tested in trial NCT06001268?

The interventions under investigation include: Fitbit Data Collection (BEHAVIORAL), Nutrition Counseling (BEHAVIORAL), Survey (BEHAVIORAL).

Who is sponsoring clinical trial NCT06001268?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06001268 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pancreatic Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.